Home / News
-
-
Belgian molecular laboratory software vendor UgenTec said Thursday that it has entered into a deal with Thermo Fisher Scientific to jointly commercialize several new CE-marked respiratory assay plug-ins for its FastFinder analysis software.2022-09-16View More
-
-
On September 14, Shanghai Upper Bio-Tech Pharma Co., Ltd. was listed on the National Equities Exchange and Quotations (NEEQ) in China market. The transaction method is call auction, and the level to which it belongs is the basic layer.2022-09-15View More
-
-
DiaSorin said Wednesday it had gained US Food and Drug Administration 510(k) clearance for a swab-based COVID-19 PCR assay that delivers results in about one hour.2022-09-15View More
-
-
Illumina said on Wednesday that its Illumina Accelerator program has invested in six new startups from around the world.2022-09-15View More
-
-
Recently, the AutraMic mini4800 Plus developed by Shanghai ZJ Bio-Tech Co.,Ltd. was approved by National Medical Products Administration. It was the smallest and more automated integrated magnetic bead method + fluorescent PCR nucleic acid detection system.2022-09-14View More
-
-
NanoSpot.ai and Athroa subsidiary Opto announced Tuesday a commercial and distribution partnership for European sales of NanoSpot.ai's point-of-care SARS-CoV-2 Total Antibody Test.2022-09-14View More
-
-
Oxford Nanopore Technologies reported on Tuesday morning that its revenues in the first half of 2022 more than doubled year over year, driven by COVID-19 testing.2022-09-14View More
-
-
It was reported on September 9 that Lanyu Bio, a domestic high-tech enterprise for in vitro diagnostics, announced the completion of the D2 round of financing of nearly CNY 100 million.2022-09-13View More
-
-
MagBio Genomics said on Monday that it has received US Food and Drug Administration 510(k) clearance, as well as CE marking, for its MagXtract Collection Tube for viral sample collection.2022-09-13View More
-
-
Adaptive Biotechnologies on Monday said that it has signed a nondilutive financing agreement with investment firm OrbiMed that will give it access to as much as $250 million in exchange for a portion of its revenues.2022-09-13View More
-
-
On September 9, 2022, MGI Tech Co., Ltd. was listed on the STAR Market. The stock name is Huada Zhizao, the stock code is 688114. SH, with the issue price is 87.18 CNY / share, and the opening price is 107 CNY / share. MGI is an affiliated company of the Listed Company BGI.2022-09-09View More
-
-
Becton Dickinson and Viramed Biotech each gained US Food and Drug Administration 510(k) clearance in August for panels to differentiate pathogenic illnesses, and a Werfen subsidiary got the go-ahead for a panel used to evaluate coagulation pathways and Vitamin K antagonist treatment.2022-09-09View More
-
-
Morgan Health, JPMorgan Chase's healthcare-focused business unit, said on Thursday that it had invested $20 million in at-home testing company LetsGetChecked.2022-09-09View More
-
-
Chris Lee aims to transform healthcare fundraising through VentureBlick¡¯s fundraising platform and professional community2022-09-08View More
-
-
The US Department of Health and Human Services announced on Wednesday that it has authorized the Food and Drug Administration to issue emergency use authorizations for monkeypox tests.2022-09-08View More
-
-
France's Lesaffre said on Wednesday that it has acquired genome engineering firm Recombia Biosciences.2022-09-08View More
-
-
UK-based molecular diagnostics system developer QuantuMDx said on Tuesday that it has entered into a global R&D, manufacturing, and commercial partnership agreement with Sansure Biotech aimed at commercializing its Q-POC system and assays in China.2022-09-07View More
-
-
Illumina said on Tuesday that it has received a decision from the European Commission that will prohibit the firm from keeping liquid biopsy maker Grail.2022-09-07View More
-
-
The H1 reports of Chinese listed companies in 2022 have all been revealed.2022-09-07View More
-
-
Stock price review: centralized procurement VS epidemic, differentiated growth and excess earnings. Two peaks in January 2022 and March-April 2022. IVD, low-value consumables, etc. performed prominently, mainly driven by the epidemic2022-09-06View More
- CAIVD WeChat
Subscription Account
- CAIVD WeChat
Channels
China Association of In-vitro Diagnostics
Part of the information in our website is from the internet.
If by any chance it violates your rights, please contact us.